Apitope Announce Positive Peptide Therapy Results MStranslate February 28, 2017 Research, Treatments Imagine you have a dog and a cat and they keep fighting. Solution 1: give one of your pets to someone else. Solution 2: Teach them to get along. Solution 1 describes almost all current MS...
MS: Many Stories – From the MStranslate Community MStranslate February 26, 2017 Community, Exercise, Lifestyle, MS: Many Stories Welcome to part 3 of a series of articles being written by MStranslate community member, Andrew. You may remember Andrew from a video we featured in late 2016, introducing the potential benefits of pilates...
Can Blood Test Determine Type of Multiple Sclerosis? MStranslate February 8, 2017 Basic Sciences, Research Research Summary: Kynurenine pathway metabolomics predicts and provides mechanistic insight into multiple sclerosis progression A recent Australian research breakthrough in multiple sclerosis (MS) has drawn...
HALT-MS: Five Year Study Results MStranslate February 2, 2017 Research, Stem Cells, Treatments Research Summary: High dose immunosuppressive therapy and autologous HCT for relapsing-remitting MS The 5 year results of the HALT-MS trial were today published in Neurology. The HALT-MS clinical trial has...
A Balancing Act – The Role of Humour in MS MStranslate January 31, 2017 Opinion 2 Comments An opinion piece by MStranslate co-founder, Brett Drummond As you may have seen recently, we have been running a series of MS: Many Stories articles written by one of our community members, Andrew. As he...
MS: Many Stories – From the MStranslate Community MStranslate January 28, 2017 Community, Fatigue, MS: Many Stories, Symptoms Welcome to part 2 of a series of articles being written by MStranslate community member, Andrew. You may recognise Andrew from a video we featured in late 2016, introducing the potential benefits of pilates...
Case Studies Reveal New Alemtuzumab Side-effects MStranslate January 26, 2017 Alemtuzumab, Research, Treatments Research Summary: Severe B-cell-mediated CNS disease secondary to alemtuzumab therapy A recent report in Lancet Neurology has highlighted two case studies of severe side effects in people with MS receiving...
MS: Many Stories – From the MStranslate Community MStranslate January 24, 2017 Community, MS: Many Stories Welcome to part 1 of a series of articles being written by MStranslate community member, Andrew. You may recognise Andrew from a video we featured in late 2016, introducing the potential benefits of pilates...
Dimethyl Fumarate Linked to Liver Injury MStranslate January 17, 2017 Dimethyl fumarate, Research, Treatments Research Summary: Liver injury associated with dimethyl fumarate in multiple sclerosis patients Last Friday, members of the Office of Surveillance and Epidemiology at the US FDA published a brief report in...
Ocrelizumab in Primary Progressive MS MStranslate January 13, 2017 Ocrelizumab, Research, Treatments Research Summary: Ocrelizumab versus Placebo in Primary Progressive Multiple Sclerosis There has been a lot of hype over ocrelizumab as the next ‘wonder drug’ in MS. This has mostly come from the early...
